Also, JNK1/2 deficiency promotes tumor formation in a KRAS/P53 mouse model of breast cancer41, whereas inactivation of MKK4 or MKK7, which are upstream activators of JNK1/2, is associated with oncogenic transformation in the mouse mammary gland42,43. This evidence concerns the gene MAP2K4 and neoplasm.